Precision Oncology: Targeting Molecular Subtypes in Cancer Therapy
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 30 October 2025 | Viewed by 613
Special Issue Editors
2. Yamagata Hereditary Tumor Research Center, Yamagata University, 1-4-12 Kojirakawa, Yamagata 990-8560, Japan
3. Department of Clinical Oncology, School of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata 990-9585, Japan
4. Department of Molecular Cancer Science, Yamagata University, 2-2-2 Iida-Nishi, Yamagata 990-9585, Japan
Interests: drug resistance; cancer stem cells; drug repositioning; cancer genomic testing; germline mutation; genetic cancer; genetic counseling
Special Issue Information
Dear Colleagues,
Precision oncology has revolutionized cancer treatment by identifying specific molecular alterations that drive tumor growth and developing targeted therapies against these alterations. This shift from the traditional approach to personalized medicine has led to remarkable improvements in patient outcomes across multiple cancer types.
This Special Issue, entitled "Precision Oncology: Targeting Molecular Subtypes in Cancer Therapy", aims to explore current challenges and future directions in molecular subtyping for cancer treatment. We seek to highlight innovative approaches for identifying and targeting specific molecular subtypes, overcoming resistance mechanisms, and implementing precision diagnostics in clinical practice.
Recent technological advances in genomic profiling, liquid biopsies, and artificial intelligence have dramatically enhanced our ability to identify actionable molecular alterations and monitor treatment response in real time. These developments create unprecedented opportunities for refining treatment selection and developing novel therapeutic strategies for molecularly defined patient subgroups.
We invite the submission of original research articles and comprehensive reviews addressing molecular subtyping methodologies, biomarker discovery, resistance mechanisms, multi-omics integration, emerging diagnostic technologies, and innovative clinical trial designs for molecular subtypes in oncology.
Dr. Shuhei Suzuki
Dr. Jiro Ogura
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer chemotherapy
- cancer genomic profiling test
- next-generation sequencing
- genetic variants
- molecular targeted therapy
- molecular tumor board
- liquid biopsy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
